Properties
Description
Delgocitinib is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and TYK2.
Molecular Formula
C16H18N6O
Targets
JAK1: 2.8 nM; JAK2: 2.6 nM; JAK3: 13 nM; TYK2: 58 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Delgocitinib can be employed to study JAK inhibition and its effects in dermatological and inflammatory conditions.